首页> 外文期刊>Atherosclerosis >Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians
【24h】

Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians

机译:非酒精性脂肪肝与亚洲印第安人独立于肥胖和代谢综合症的亚临床动脉粥样硬化相关

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: We examined the association of subclinical atherosclerosis and endothelial dysfunction with nonalcoholic fatty liver disease (NAFLD) in Asian Indians. Methods: This study included 40 non-diabetic subjects with NAFLD and 40 apparently healthy controls without NAFLD with similar age, gender and body mass index. Measurements included anthropometric parameters, oral glucose tolerance test, fasting and 2 h insulin, lipid profile, C-reactive protein, sICAM-1, VCAM-1, carotid intima-media thickness (CIMT) and brachial artery flow mediated dilatation (FMD). Results: Subjects with NAFLD had higher average and maximum CIMT (0.6 ± 0.12 and 0.684 ± 0.16 mm, respectively, vs 0.489 ± 0.1 and 0.523 ± 0.1 mm, respectively; p < 0.05), and had higher prevalence of atherosclerotic plaques (20% vs 5%, p < 0.05) than controls. Significantly greater degree of impairment in FMD and higher levels of hs-CRP and sICAM-1 were observed in NAFLD patients than controls. The presence of NAFLD was observed to be the independent predictor of having high average CIMT (OR 4.8; 95% CI: 1.8-12.8), high maximum CIMT (OR 5.4; 95% CI: 2.0-14.4) and impaired FMD (OR 11.7; 95% CI: 1.4-96.5) even after adjusting for obesity, metabolic syndrome, insulin resistance and lipid parameters. Conclusion: In Asian Indians NAFLD is significantly associated with subclinical atherosclerosis and endothelial dysfunction independent of obesity and metabolic syndrome. Elevated levels of hs-CRP and sICAM-1 may be useful as indicators of liver injury in NAFLD.
机译:目的:我们研究了亚洲印第安人的亚临床动脉粥样硬化和内皮功能障碍与非酒精性脂肪肝疾病(NAFLD)的关系。方法:本研究包括40名患有NAFLD的非糖尿病受试者和40名年龄,性别和体重指数相似的无NAFLD的显然健康的对照。测量包括人体测量学参数,口服葡萄糖耐量测试,禁食和2 h胰岛素,脂质分布,C反应蛋白,sICAM-1,VCAM-1,颈动脉内膜中层厚度(CIMT)和肱动脉血流介导的扩张(FMD)。结果:NAFLD患者的平均CIMT和最大CIMT较高(分别为0.6±0.12和0.684±0.16 mm,而分别为0.489±0.1和0.523±0.1 mm; p <0.05),并且动脉粥样硬化斑块的患病率较高(20% vs 5%,p <0.05)。与对照组相比,在NAFLD患者中观察到FMD损伤程度更高,hs-CRP和sICAM-1水平更高。观察到NAFLD的存在是高平均CIMT(OR 4.8; 95%CI:1.8-12.8),高最高CIMT(OR 5.4; 95%CI:2.0-14.4)和FMD受损(OR 11.7)的独立预测因子。 ; 95%CI:1.4-96.5),即使在调整了肥胖,代谢综合征,胰岛素抵抗和脂质参数之后也是如此。结论:在亚洲印第安人中,NAFLD与亚临床动脉粥样硬化和内皮功能障碍密切相关,而与肥胖症和代谢综合征无关。 hs-CRP和sICAM-1的水平升高可能是NAFLD肝损伤的指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号